Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Aladdin

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Scandinavian Journal of Immunology|March 17, 2001
Effects of subcutaneous IL-2 therapy on telomere lengths in PBMC in HIV-infected patientsH Aladdin, C S Larsen, P Schjerling, et al.
The Journal of Infectious Diseases|March 18, 2000
Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trialH Aladdin, H Ullum, S Dam Nielsen, et al.
AIDS (London, England)|April 15, 1999
Natural immunity and HIV disease progressionH Ullum, A Cozzi Lepri, H Aladdin, et al.
Scandinavian Journal of Immunology|August 10, 2000
Effects of G-CSF on telomere lengths in PBMCs from human immunodeficiency virus-infected patients: results from a randomized, placebo-controlled trialH Aladdin, H Ullum, P Schjerling, et al.
Scandinavian Journal of Immunology|September 6, 2000
The effect of long-term treatment with granulocyte colony-stimulating factor on hematopoiesis in HIV-infected individualsS D Nielsen, T U Sørensen, H Aladdin, et al.
Scandinavian Journal of Immunology|August 14, 1999
Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of deathH Aladdin, H Ullum, A C Lepri, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Scandinavian Journal of Immunology|March 17, 2001
Effects of subcutaneous IL-2 therapy on telomere lengths in PBMC in HIV-infected patientsH Aladdin, C S Larsen, P Schjerling, et al.
The Journal of Infectious Diseases|March 18, 2000
Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trialH Aladdin, H Ullum, S Dam Nielsen, et al.
AIDS (London, England)|April 15, 1999
Natural immunity and HIV disease progressionH Ullum, A Cozzi Lepri, H Aladdin, et al.
Scandinavian Journal of Immunology|August 10, 2000
Effects of G-CSF on telomere lengths in PBMCs from human immunodeficiency virus-infected patients: results from a randomized, placebo-controlled trialH Aladdin, H Ullum, P Schjerling, et al.
Scandinavian Journal of Immunology|September 6, 2000
The effect of long-term treatment with granulocyte colony-stimulating factor on hematopoiesis in HIV-infected individualsS D Nielsen, T U Sørensen, H Aladdin, et al.
Scandinavian Journal of Immunology|August 14, 1999
Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of deathH Aladdin, H Ullum, A C Lepri, et al.
Pageof 2